{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "340",
                "347"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Ezoleta"
        },
        {
            "identifier": "T2",
            "position": [
                "577",
                "597"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Hipercholesterolemia"
        },
        {
            "identifier": "T3",
            "position": [
                "599",
                "612"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Nietolerancja"
        },
        {
            "identifier": "T4",
            "position": [
                "613",
                "619"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "statyn"
        },
        {
            "identifier": "T5",
            "position": [
                "621",
                "655"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "\u0141agodna niedomykalno\u015b\u0107 tr\u00f3jdzielna"
        },
        {
            "identifier": "T6",
            "position": [
                "657",
                "687"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Upo\u015bledzona tolerancja glukozy"
        },
        {
            "identifier": "T7",
            "position": [
                "698",
                "722"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zapalenie b\u0142ony \u015bluzowej"
        },
        {},
        {
            "identifier": "T8",
            "position": [
                "735",
                "754"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zaka\u017cenia H. pylori"
        },
        {
            "identifier": "T9",
            "position": [
                "918",
                "938"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "hipercholesterolemii"
        },
        {
            "identifier": "T10",
            "position": [
                "941",
                "954"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "nietolerancji"
        },
        {
            "identifier": "T11",
            "position": [
                "955",
                "961"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "statyn"
        },
        {
            "identifier": "T12",
            "position": [
                "963",
                "974"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "b\u00f3le mi\u0119\u015bni"
        },
        {
            "identifier": "T13",
            "position": [
                "976",
                "1007"
            ],
            "subtype": "Investigation_result",
            "type": "T",
            "value": "podwy\u017cszone parametry w\u0105trobowe"
        },
        {
            "identifier": "T14",
            "position": [
                "1069",
                "1099"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "upo\u015bledzona tolerancja glukozy"
        },
        {
            "identifier": "T15",
            "position": [
                "1110",
                "1142"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zapalenie b\u0142ony \u015bluzowej \u017co\u0142\u0105dka"
        },
        {
            "identifier": "T16",
            "position": [
                "1145",
                "1165"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "eredykacji H. pylori"
        },
        {
            "identifier": "T17",
            "position": [
                "1168",
                "1175"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "Obecnie"
        },
        {
            "identifier": "T18",
            "position": [
                "1187",
                "1197"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "metformina"
        },
        {
            "identifier": "T19",
            "position": [
                "1199",
                "1206"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Omega 3"
        },
        {
            "identifier": "T20",
            "position": [
                "1241",
                "1261"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "hipercholesterolemia"
        },
        {
            "identifier": "T21",
            "position": [
                "1234",
                "1238"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "PTCA"
        },
        {
            "identifier": "T22",
            "position": [
                "1263",
                "1270"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Alergie"
        },
        {
            "identifier": "T23",
            "position": [
                "1272",
                "1278"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "neguje"
        },
        {
            "icd": "ICD10:E78.0",
            "identifier": "N1",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Czysta hipercholesterolemia"
        },
        {
            "icd": "ICD10:Z88",
            "identifier": "N2",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenia na leki, \u00c5\u009brodki farmakologiczne i substancje biologiczne w wywiadzie"
        },
        {
            "icd": "ICD10:R73.0",
            "identifier": "N3",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Nieprawid\u00c5\u0082owe wyniki testu tolerancji glukozy"
        },
        {
            "icd": "ICD10:E78.0",
            "identifier": "N4",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Czysta hipercholesterolemia"
        },
        {
            "icd": "ICD10:Z88",
            "identifier": "N5",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenia na leki, \u00c5\u009brodki farmakologiczne i substancje biologiczne w wywiadzie"
        },
        {
            "icd": "ICD10:R51",
            "identifier": "N6",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "B\u00c3\u00b3l g\u00c5\u0082owy"
        },
        {
            "icd": "ICD10:R73.0",
            "identifier": "N7",
            "referenced": "T14",
            "subtype": "Reference",
            "type": "N",
            "value": "Nieprawid\u00c5\u0082owe wyniki testu tolerancji glukozy"
        },
        {
            "icd": "ICD10:K29.7",
            "identifier": "N8",
            "referenced": "T15",
            "subtype": "Reference",
            "type": "N",
            "value": "Zapalenie \u00c5\u00bco\u00c5\u0082\u00c4\u0085dka, nieokre\u00c5\u009blone"
        },
        {
            "icd": "ICD10:E78.0",
            "identifier": "N9",
            "referenced": "T20",
            "subtype": "Reference",
            "type": "N",
            "value": "Czysta hipercholesterolemia"
        },
        {
            "icd": "ICD10:Z91.0",
            "identifier": "N10",
            "referenced": "T22",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenie na czynniki inne ni\u00c5\u00bc leki i substancje biologiczne w wywiadzie"
        },
        {
            "arg1": "T23",
            "arg2": "T22",
            "identifier": "R10",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T10",
            "arg2": "T11",
            "identifier": "R3",
            "subtype": "Alg",
            "type": "R"
        },
        {
            "arg1": "T17",
            "arg2": "T15",
            "identifier": "R5",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T17",
            "arg2": "T16",
            "identifier": "R6",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "identifier": "A1",
            "referenced": "T20",
            "subtype": "Status",
            "type": "A",
            "value": "Family"
        },
        {
            "identifier": "A2",
            "referenced": "T21",
            "subtype": "Status",
            "type": "A",
            "value": "Family"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 51 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nEzoleta.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:E78.0|Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Hipercholesterolemia. Nietolerancja statyn. \u0141agodna niedomykalno\u015b\u0107 tr\u00f3jdzielna. Upo\u015bledzona tolerancja glukozy. Przebyte zapalenie b\u0142ony \u015bluzowej w przebiegu zaka\u017cenia H. pylori w wywiadzie.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nPacjent lat 51 z wywiadem hipercholesterolemii i nietolerancji statyn (b\u00f3le mi\u0119\u015bni, podwy\u017cszone parametry w\u0105trobowe), zosta\u0142 przyj\u0119ty do Kliniki celem diagnostyki. W wywiadzie: upo\u015bledzona tolerancja glukozy, przebyte zapalenie b\u0142ony \u015bluzowej \u017co\u0142\u0105dka i eredykacji H. pylori.. Obecnie przyjmuje: metformina, Omega 3.\nWywiad rodzinny: matka po PTCA z hipercholesterolemia.\nAlergie: neguje.\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:7.34[10^3/ul]\n    RBC Krwinki czerwone:4.90[10^6/ul]\n    HGB Hemoglobina:15.2[g/dl]\n    HCT Hematokryt:43.1[%]\n    MCV wska\u017anik czerwonokrw:88.0[fl]\n    MCH wska\u017anik czerwonokrw:31.0[pg]\n    MCHC wska\u017anik czerwonokr:35.3[g/dl]\n    PLT z morfologii:219[10^3/ul]\n    RDW-SD:39.3[fl]\n    RDW-CV:12.2[%]\n    PDW:11.7[fl]\n    MPV:10.1[fl]\n    P-LCR:26.2[%]\n    PCT (hematokryt p\u0142ytkowy:0.22[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:4.29[10^3/ul]\n    NEUTR%:58.5[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:2.56[10^3/ul]\n    LYMPH%:34.9[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.41[10^3/ul]\n    MONO%:5.6[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.04[10^3/ul]\n    EO%:0.5[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.04[10^3/ul]\n    BASO%:0.5[%]\n    NRBC %:0.0[%]\n    NRBC #:0.00[10^3/ul]\nD-dimer - test ilo\u015bciowy: D-dimer - test ilo\u015bciowy:219[ng/ml]\nBadanie og\u00f3lne moczu\n    barwa:jasnozolty[ ]\n    glukoza:nieobecna[ ]\n    bilirubina:nieobecna[ ]\n    przejrzysto\u015b\u0107:zupelna[ ]\n    cia\u0142a ketonowe:nieobecne[mg/dl]\n    ci\u0119\u017car w\u0142a\u015bciwy:1.012[ ]\n    kwas askrobinowy:nieobecny[ ]\n    pH:6.0[ ]\n    bia\u0142ko:nieobecne[ ]\n    urobilinogen:niewzmozony[ ]\n    azotyny:nieobecne[ ]\n    erytrocyty:obecne[ ]\n    leukocyty:nieobecne[ ]\n    OSAD MOCZU:AUTOMATYCZNY[ ]\n    nab\u0142onki p\u0142askie:nieliczne[w preparacie]\n    leukocyty:18 /ul[ul]\n    erytrocyty \u015bwie\u017ce i cz\u0119\u015b:19/ul[ul]\n    \u015bluz:pojedyncze pasma[w preparacie]\n    bakterie:nieliczne[w preparacie]\nTSH: TSH:1.57[uIU/ml]\nFT3: FT3:3.03[pg/ml]\nFT4: FT4:0.99[ng/dl]\nALAT: ALAT:47[U/L]\nASPAT: ASPAT:35[U/L]\nCK - aktywno\u015b\u0107: CK:506[U/L]\nCK - aktywno\u015b\u0107: CK:451[U/L]\nCRP Bia\u0142ko C-reaktywne: CRP Bia\u0142ko C-reaktywne:0.57[mg/dl]\nS\u00f3d (Na): S\u00f3d:146[mmol/L]\nPotas (K): Potas:5.0[mmol/L]\nHemoglobina glikowana (HbA1c)\n    :5.51[%]\n    :37[mmol/mol]\nKreatynina + GFR\n    Kreatynina w surowicy:0.96[mg/dl]\n    eGFR wg skr.MDRD ze stan:82.6[ml/min/1,73 m^2]\nMocznik: Mocznik:24[mg/dl]\nKwas moczowy: Kwas moczowy:7.4[mg/dl]\nLipidogram\n    Cholesterol ca\u0142kowity:322[mg/dl]\n    Cholesterol HDL:50[mg/dl]\n    Cholestrol LDL:232[mg/dl]\n    Triglicerydy:100[mg/dl]\n    Stosunek cholesterolu HD:0.2\nGlukoza w surowicy: Glukoza w surowicy:117[mg/dl]\nNT-proBNP surowica: NT-proBNP w surowicy:25[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nI07.1\nE78.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.501\n88.721\n------------------------------------------------"
}